Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Association of surgical complexity with patient-reported outcomes among patients with ovarian cancer.
Journal: Gynecologic oncology
Published: February 09, 2026
First-In-Human Trial of Encapsulated Cell-Based Protein Producers for Localized IL-2 in Patients with High-Grade Serous Ovarian Carcinoma.
Journal: medRxiv : the preprint server for health sciences
Published: November 26, 2025
First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 14, 2025
Same day discharge after minimally invasive interval debulking surgery in advanced stage ovarian cancer.
Journal: Gynecologic oncology
Published: November 08, 2025
Corrigendum to "OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer" [Gynecol Oncol 2025 Jun 197 182-191].
Journal: Gynecologic oncology
Published: November 07, 2025
Neoadjuvant Chemotherapy, Case Volume, and Mortality in Advanced Ovarian Cancer.
Journal: JAMA network open
Published: July 25, 2025
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer.
Journal: Gynecologic oncology
Published: April 08, 2025
Decline in Rate of Radical Hysterectomies Performed by Gynecologic Oncologists in the United States.
Decline in Rate of Radical Hysterectomies Performed by Gynecologic Oncologists in the United States.
Journal: Obstetrics and gynecology
Published: April 07, 2025
Hypoxia induced VEGF secretion promotes resistance to bispecific T-cell engagers.
Journal: Signal transduction and targeted therapy
Published: March 16, 2025
Utilization of Primary Cytoreductive Surgery for Advanced-Stage Ovarian Cancer.
Journal: JAMA network open
Published: October 16, 2024
The association of maintenance hormone therapy with overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study.
Journal: Gynecologic oncology
Published: April 27, 2024
Last Updated: 09/26/2026